Thrombolytic therapy in acute ischaemic stroke

Cerebrovascular Diseases

Volumn 13, Issue 3, 2002, Pages 163-167

  Thomassen, Lars ^a   Waje Andreassen, Ulrike ^a   Morsund, Åse Hagen ^a   Hordnes, Julie ^a   Maintz, Corinna ^a   Smievoll, Alf I ^a   Russell, David ^b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Acute stroke; Cerebral infarction; Thrombolysis

Indexed keywords

ALTEPLASE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BRAIN HEMATOMA; BRAIN HEMORRHAGE; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; DISEASE SEVERITY; DRUG EFFECT; DRUG SAFETY; FEASIBILITY STUDY; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; WARD;

AGED; CEREBRAL ANGIOGRAPHY; CEREBRAL HEMORRHAGE; DECISION MAKING; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NORWAY; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 0036204286     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000047770     Document Type: Article

References (21)

1. Tissue plasminogen activator for acute ischemic stroke
2. Thrombolysis for acute ischaemic stroke
3. Practice advisory: Thrombolytic therapy for acute ischemic stroke - Summary statement
4. Guidelines for thrombolytic therapy for acute stroke: A supplement to the guidelines for the management of patients with acute ischemic stroke
5. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke
6. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)
7. Acute stroke: Usefulness of early CT findings before thrombolytic therapy
8. Evaluation of early computed tomographic findings in acute ischemic stroke
9. Classification and natural history of clinically identifiable subtypes of acute cerebral infarction
10. Early intravenous thrombolysis for acute ischemic stroke in a community-based approach
11. Intravenous tissue-type plasminogen activator for treatment of acute stroke
12. Effectiveness of t-PA in acute ischemic stroke: Outcome relates to appropriateness
13. Intravenous tissue plasminogen activator for acute ischemic stroke: Feasibility, safety, and efficacy in the first year of clinical practice
14. Hemorrhagic transformation within 36 hours of a cerebral infarct: Relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort
15. Acute ischemic strokes improving during the first 48 hours of onset: Predictability, outcome, and possible mechanisms. A comparison with early deteriorating strokes
16. Deterioration following spontaneous improvement. Sonographic findings in patients with acutely resolving symptoms of cerebral ischemia
17. Early spontaneous improvement and deterioration of ischemic stroke patients. A serial study with transcranial Doppler ultrasonography
18. Effects of spontaneous recanalization on functional and electrophysiological recovery in acute ischemic stroke
19. Computed tomography findings in the first few hours of ischemic stroke: Implications for clinicians
20. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator
21. Association of hyperdense middle cerebral artery sign with clinical outcome in patients treated with tissue plasminogen activator